"Designing Growth Strategies is in our DNA"

Chronic Pain Drugs Market Size, Share & Industry Analysis, By Drug Class (NSAIDs, Opioids, Antidepressants, Anticonvulsants / Gabapentinoids, Topical Analgesics, Local Anesthetics, & Others), By Disease Indication (Musculoskeletal Pain, Neuropathic Pain, Cancer-related Pain, Postsurgical / Post-traumatic Pain, Visceral Pain, & Others), By Age Group (Pediatric & Adult), By Type (Branded & Generic), By Route of Administration (Oral & Parenteral), By Distribution Channel (Hospital Pharmacies, Specialty pharmacies, Drug Stores & Retail Pharmacies, & Others), and Regional Forecast, 2026-2034

Last Updated: April 16, 2026 | Format: PDF | Report ID: FBI115944

 

  • 2021-2034
  • 2025
  • 2021-2024
  • 190
Download Free Sample

    man icon
    Mail icon

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann